These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective pricing and the implications for patient education. Giloth B Promot Health; 1983; 4(6):4-5, 11. PubMed ID: 10273424 [No Abstract] [Full Text] [Related]
3. Learning to live with prospective pricing: a patient education challenge. Kinnaird LS Promot Health; 1985; 6(1):6-8. PubMed ID: 10273613 [No Abstract] [Full Text] [Related]
4. Third party reimbursement for diabetes care. I. The prospective payment system: implications for diabetes patient education. Schwartz R Diabetes Educ; 1985; 11(2):70. PubMed ID: 3852734 [No Abstract] [Full Text] [Related]
6. The establishment of a reimbursable diabetes education program. Davidson MB; Morgan R; Bales B; Pearce MA; Crane M; Graham B Diabetes Educ; 1982; 8(3):31-3, 38. PubMed ID: 6754306 [No Abstract] [Full Text] [Related]
7. Third-party reimbursement for diabetes care, self-management education, and supplies. American Diabetes Association Diabetes Care; 2007 Jan; 30 Suppl 1():S86-7. PubMed ID: 17192384 [No Abstract] [Full Text] [Related]
8. Accomplishing more with less under PPS using patient education. Bartlett EE Healthc Financ Manage; 1985 Jul; 39(7):86-94. PubMed ID: 10300176 [TBL] [Abstract][Full Text] [Related]
9. Issues in diabetes education. Hinnen D Nurs Clin North Am; 1993 Mar; 28(1):113-20. PubMed ID: 8451202 [TBL] [Abstract][Full Text] [Related]
10. Issues of reimbursement. Fain JA Diabetes Educ; 1989; 15(6):487. PubMed ID: 2627864 [No Abstract] [Full Text] [Related]
11. Third-party coverage for diabetes education program. Schwartz R; Zaremba M; Ra K QRB Qual Rev Bull; 1985 Jul; 11(7):213-7. PubMed ID: 3929205 [No Abstract] [Full Text] [Related]
12. Prospective payment: what it is and implications for patient education. Schwartz R Patient Educ Couns; 1984; 6(2):61-3. PubMed ID: 10310786 [No Abstract] [Full Text] [Related]
13. The specter of prospective reimbursement. Bartlett EE Patient Educ Newsl; 1983 Feb; 6(1):11. PubMed ID: 10273369 [No Abstract] [Full Text] [Related]
14. Prospective payment and the educational component. Levin LS Patient Educ Couns; 1984; 6(2):66-8. PubMed ID: 10273573 [No Abstract] [Full Text] [Related]
15. Prospective payment: a view from the trenches. Cioffi JP Patient Educ Couns; 1984; 6(2):63-6. PubMed ID: 10273572 [No Abstract] [Full Text] [Related]
16. The value of diabetes education: is it cost-effective? Fain JA Diabetes Educ; 2009; 35(5):683. PubMed ID: 19783763 [No Abstract] [Full Text] [Related]
17. Impact of prospective payment on the role of the diabetes educator. Martinez NC; Deane DM Diabetes Educ; 1989; 15(6):503-9. PubMed ID: 2697543 [TBL] [Abstract][Full Text] [Related]
18. Responding to the prospective pricing challenge: 1984 patient education leaders point the way. Kernaghan SG Promot Health; 1984; 5(6):suppl 1-12. PubMed ID: 10273631 [No Abstract] [Full Text] [Related]
19. CHA study shows what Michigan could lose. Brusstar JG Mich Hosp; 1984 Mar; 20(3):15-7. PubMed ID: 10273471 [No Abstract] [Full Text] [Related]
20. What is effective diabetes nutrition therapy and who is qualified to provide it? Haase R; Spencer E WMJ; 1998 Mar; 97(3):36-8. PubMed ID: 9540447 [No Abstract] [Full Text] [Related] [Next] [New Search]